Skip to main content
    • Aa
    • Aa

Homocysteine increases the risk of mortality in elderly individuals

  • Sonia González (a1), José M. Huerta (a1), Serafina Fernández (a1), Ángeles M. Patterson (a1) and Cristina Lasheras (a1)...

Although total plasma homocysteine (tHcy) has been extensively studied as a risk factor of CVD, longitudinal evidence on its association with mortality is scarce, especially among the elderly. The study cohort consisted of 215 subjects (eighty-eight male and 127 female), aged 60 years or older, recruited in fourteen elderly care institutions from Asturias (Spain). All participants were free of major chronic pathology and took no vitamin and/or mineral supplements. Baseline determinations included tHcy in plasma and folate, vitamin B12 and Se in serum. Survival analyses were performed by quintiles of these factors after 6 years (mean follow-up time 4·3 years) by means of Cox regression models. During follow-up time sixty participants died. tHcy above 16·7 μmol/l was associated with an increased risk of mortality in the sample (relative risk 2·30 (95 % CI 1·02, 5·17)). Among the nutritional determinants of tHcy evaluated, folate and Se were not predictive of death risk of the cohort, while vitamin B12 showed inconsistent results. Nevertheless, mortality was significantly lower at higher serum Se levels (upper quintile), but this effect was restricted to women. Higher tHcy in both sexes and lower serum Se in women were found to be independently associated with an increased risk of death in elderly subjects.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Homocysteine increases the risk of mortality in elderly individuals
      Available formats
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Homocysteine increases the risk of mortality in elderly individuals
      Available formats
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Homocysteine increases the risk of mortality in elderly individuals
      Available formats
Corresponding author
*Corresponding author: Dr Cristina Lasheras, fax +34 98 5103534, email
Hide All
Akbaraly NT, Arnaud J, Hininger-Favier I, Gourlet V, Roussel AM & Berr C (2005) Selenium and mortality in the elderly: Results from the EVA Study. Clin Chem 51, 21172123.
Anderson JL, Muhlestein JB, Horne BD, Carlquist JF, Bair TL, Madsen TE & Pearson RR (2000) Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease. Circulation 102, 12271232.
Araki A & Sako Y (1987) Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 422, 4352.
Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E & Rasmussen K (2006) Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354, 15781588.
Bostom AG, Silbershatz H, Rosenberg IH, Selhub J, D'Agostino RB, Wolf PA, Jacques PF & Wilson PW (1999) Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med 159, 10771080.
Boushey CJ, Beresford SA, Omenn GS & Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274, 10491057.
Brouwer IA, Verhoef P & Urgert R (2000) Betaine supplementation and plasma homocysteine in healthy volunteers. Arch Intern Med 160, 25462547.
Buccianti G, Baragetti I, Bamonti F, Furiani S, Dorighet V & Patrosso C (2004) Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease. J Nephrol 17, 405410.
Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L & Ueland PM (1998) Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 55, 14491455.
de Bree A, Verschuren WM, Blom HJ, Nadeau M, Trijbels FJ & Kromhout D (2003) Coronary heart disease mortality, plasma homocysteine, and B-vitamins: a prospective study. Atherosclerosis 166, 369377.
Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF Jr, Slate EH, Fischbach LA, Marshall JR & Clark LC (2002) Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 11, 630639.
Egerton W, Silberberg J, Crooks R, Ray C, Xie L & Dudman N (1996) Serial measures of plasma homocyst(e)ine after acute myocardial infarction. Am J Cardiol 77, 759761.
Finkelstein JD (1990) Methionine metabolism in mammals. J Nutr Biochem 1, 228237.
González S, Huerta JM, Álvarez-Uría J, Fernández S, Patterson AM & Lasheras C (2004) Serum selenium is associated with plasma homocysteine concentrations in elderly humans. J Nutr 134, 17361740.
Graham IM, Daly LE, Refsum HM, et al. (1997) Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 277, 17751781.
Hankey GJ & Eikelboom JW (1999) Homocysteine and vascular disease. Lancet 354, 407413.
Heyland DK, Dhaliwal R, Suchner U & Berger MM (2005) Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med 31, 327337.
Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288, 20152022.
Huerta JM, González S, Vigil E, Prada M, San Martín J, Fernández S, Patterson AM & Lasheras C (2004) Folate and cobalamin synergistically decrease the risk of high plasma homocysteine in a nonsupplemented elderly institutionalized population. Clin Biochem 37, 904910.
Jacobson BE & Lockitch G (1988) Direct determination of selenium in serum by graphite-furnace atomic absorption spectrometry with deuterium background correction and a reduced palladium modifier: age-specific reference ranges. Clin Chem 34, 709714.
Jacques PF, Bostom AG, Wilson PW, Rich S, Rosenberg IH & Selhub J (2001) Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 73, 613621.
Jacques PF, Kalmbach R, Bagley PJ, Russo GT, Rogers G, Wilson PW, Rosenberg IH & Selhub J (2002) The relationship between riboflavin and plasma total homocysteine in the Framingham Offspring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene. J Nutr 132, 283288.
Kark JD, Selhub J, Adler B, Gofin J, Abramson JH, Friedman G & Rosenberg IH (1999) Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem. Ann Intern Med 131, 321330.
Kasiske BL & Keane WF (1996) Laboratory assessment of renal disease clearance, urinalysis and renal biopsy. In The Kidney, pp. 11371173 [Brenner BM and Rector FC Jr, editors]. Philadelphia: WB Saunders.
Kok FJ, de Bruijn AM, Hofman A, Vermeeren R & Valkenburg HA (1987 a\) Is serum selenium a risk factor for cancer in men only? Am J Epidemiol 125, 1216.
Kok FJ, de Bruijn AM, Vermeeren R, Hofman A, van Laar A, de Bruin M, Hermus RJ & Valkenburg HA (1987 b\) Serum selenium, vitamin antioxidants, and cardiovascular mortality: a 9-year follow-up study in the Netherlands. Am J Clin Nutr 45, 462468.
Lasheras C, González S, Huerta JM, Lombardía C, Ibáñez R, Patterson AM & Fernández S (2003) Food habits are associated with lipid peroxidation in an elderly population. J Am Diet Assoc 103, 14801487.
Lindgren A, Brattstrom L, Norrving B, Hultberg B, Andersson A & Johansson BB (1995) Plasma homocysteine in the acute and convalescent phases after stroke. Stroke 26, 795800.
Lobo A, Saz P & Marco C (2005) Demencias. In Medición Clínica en Psiquiatría y Psicología, pp. 335347 [Bulbena A, Berrios GE and Fernández de Larrinoa P, editors]. Barcelona: Masson.
Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C & Genest J Jr (2006) Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354, 15671577.
Morris MS (2003) Homocysteine and Alzheimer's disease. Lancet Neurol 2, 425428.
Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M & Vollset SE (1997) Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337, 230236.
Omland T, Samuelsson A, Hartford M, Herlitz J, Karlsson T, Christensen B & Caidahl K (2000) Serum homocysteine concentration as an indicator of survival in patients with acute coronary syndromes. Arch Intern Med 160, 18341840.
Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM & Shaper AG (1995) Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 346, 13951398.
Quinlivan EP, McPartlin J, McNulty H, Ward M, Strain JJ, Weir DG & Scott JM (2002) Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. Lancet 359, 227228.
Rayman MP (2000) The importance of selenium to human health. Lancet 356, 233241.
Rossi GP, Maiolino G, Seccia TM, Burlina A, Zavattiero S, Cesari M, Sticchi D, Pedon L, Zanchetta M & Pessina AC (2006) Hyperhomocysteinemia predicts total and cardiovascular mortality in high-risk women. J Hypertens 24, 851859.
Salonen JT, Alfthan G, Huttunen JK, Pikkarainen J & Puska P (1982) Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet ii, 175179.
Salonen JT, Salonen R, Penttila I, Herranen J, Jauhiainen M, Kantola M, Lappetelainen R, Maenpaa PH, Alfthan G & Puska P (1985) Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am J Cardiol 56, 226231.
Savarino L, Granchi D, Ciapetti G, Cenni E, Ravaglia G, Forti P, Maioli F & Mattioli R (2001) Serum concentrations of zinc and selenium in elderly people: results in healthy nonagenarians/centenarians. Exp Gerontol 36, 327339.
Saw SM, Yuan JM, Ong CN, Arakawa K, Lee HP, Coetzee GA & Yu MC (2001) Genetic, dietary, and other lifestyle determinants of plasma homocysteine concentrations in middle-aged and older Chinese men and women in Singapore. Am J Clin Nutr 73, 232239.
Selhub J (1999) Homocysteine metabolism. Annu Rev Nutr 19, 217246.
Selhub J, Jacques PF, Rosenberg IH, Rogers G, Bowman BA, Gunter EW, Wright JD & Johnson CL (1999) Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991–1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 131, 331339.
Selhub J, Jacques PF, Wilson PW, Rush D & Rosenberg IH (1993) Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270, 26932698.
Stehouwer CD, Gall MA, Hougaard P, Jakobs C & Parving HH (1999) Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria. Kidney Int 55, 308314.
Stranges S, Marshall JR, Trevisan M, Natarajan R, Donahue RP, Combs GF, Farinaro E, Clark LC & Reid ME (2006) Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial. Am J Epidemiol 163, 694699.
Verhoef P & de Groot LC (2005) Dietary determinants of plasma homocysteine concentrations. Semin Vasc Med 5, 110123.
Vollset SE, Refsum H, Tverdal A, Nygard O, Nordrehaug JE, Tell GS & Ueland PM (2001) Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study. Am J Clin Nutr 74, 130136.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Full text views

Total number of HTML views: 3
Total number of PDF views: 26 *
Loading metrics...

Abstract views

Total abstract views: 57 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 19th October 2017. This data will be updated every 24 hours.